Thermo Fisher Scientific Inc. (TMO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Thermo Fisher Scientific ...

    NYSE: TMO · Real-Time Price · USD
    482.09
    -0.32 (-0.07%)
    At close: Sep 10, 2025, 11:23 AM

    Thermo Fisher Scientific Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 4.01B 8.08B 8.52B 4.48B
    Short-Term Investments
    		 1.56B n/a n/a n/a
    Long-Term Investments
    		 560M 59M 155M 73M
    Other Long-Term Assets
    		 2.44B 2.38B 2.22B 3B
    Receivables
    		 9.63B 9.66B 9.43B 8.95B
    Inventory
    		 4.98B 5.09B 5.63B 5.05B
    Other Current Assets
    		 1.96B 1.76B 1.64B 1.64B
    Total Current Assets
    		 22.14B 24.59B 25.23B 20.11B
    Property-Plant & Equipment
    		 10.79B 11B 10.87B 9.86B
    Goodwill & Intangibles
    		 61.39B 60.69B 58.67B 62.07B
    Total Long-Term Assets
    		 75.18B 74.14B 71.92B 75.01B
    Total Assets
    		 97.32B 98.73B 97.15B 95.12B
    Account Payables
    		 3.08B 2.87B 3.38B 2.87B
    Deferred Revenue
    		 2.85B 2.69B 2.6B 2.65B
    Short-Term Debt
    		 2.48B 3.87B 5.85B 2.8B
    Other Current Liabilities
    		 2.94B 2.98B 3.08B 2.68B
    Total Current Liabilities
    		 13.33B 14.01B 17.01B 13.44B
    Long-Term Debt
    		 29.06B 31.31B 28.91B 32.15B
    Other Long-Term Liabilities
    		 1.61B 1.9B 1.75B 2.1B
    Total Long-Term Liabilities
    		 34.32B 37.87B 36B 40.71B
    Total Liabilities
    		 47.65B 51.88B 53.01B 54.15B
    Total Debt
    		 32.77B 36.42B 36.07B 36.34B
    Common Stock
    		 444M 442M 441M 439M
    Retained Earnings
    		 53.1B 47.36B 41.91B 35.43B
    Comprehensive Income
    		 -2.7B -3.22B -3.1B -2.33B
    Shareholders Equity
    		 49.58B 46.73B 43.98B 40.79B
    Total Investments
    		 2.12B 59M 155M 73M

    Add to Watchlist